235. Hypoparathyroidism Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 88 / Drugs : 107 - (DrugBank : 24) / Drug target genes : 5 - Drug target pathways : 7
Hypoparathyroidism and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 235 | Hypoparathyroidism |
| 65 | Primary immunodeficiency |
| 326 | Osteopetrosis |
| 70 | Spinal stenosis |
| 46 | Malignant rheumatoid arthritis |
| 162 | Pemphigoid |
| 228 | Bronchiolitis obliterans |
| 41 | Giant cell arteritis |
| 66 | IgA nephropathy |
| 56 | Behcet disease |
| 98 | Eosinophilic gastrointestinal disease |
| 271 | Ankylosing spondylitis |
| 60 | Aplastic anemia |
| 18 | Spinocerebellar degeneration |
| 50 | Dermatomyositis |
| 107 | Juvenile idiopathic arthritis |
| 298 | Hereditary pancreatitis |
| 53 | Sjogren syndrome |
| 113 | Muscular dystrophy |
| 75 | Cushing disease |
| 28 | Systemic amyloidosis |
| 19 | Lysosomal storage disease |
| 84 | Sarcoidosis |
| 299 | Cystic fibrosis |
| 85 | Idiopathic interstitial pneumonia |
| 51 | Scleroderma |
| 49 | Systemic lupus erythematosus |
| 97 | Ulcerative colitis |
| 96 | Crohn disease |
| 6 | Parkinson disease |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 68 | Ossification of the ligamentum flavum |
| 220 | Rapidly progressive glomerulonephritis |
| 30 | Distal myopathy |